NewsBenzingaTeva Pharmaceutical Industries Receives FDA Approval For DEGEVMA To Treat Bone Complications In Patients With Advanced Cancer Teva Pharmaceutical Industries Receives FDA Approval For DEGEVMA To Treat Bone Complications In Patients With Advanced Cancer Benzinga 2026.09.28 20:01 (GMT+0) Open on Benzinga Other news Tencent Cloud Issues Risk Advisory on PHP "php2shell" Remote Code Execution Vulnerability Ahead of Procter & Gamble Earnings, Here's What Barchart Data Says Comes Next for PG Stock US Treasury Secretary Bessent: GENIUS Act establishes a federal regulatory framework for payment stablecoins Ahead of Spotify Earnings, Here's What Barchart Data Says Comes Next for SPOT Stock Electric Utility NiSource’s Data-Center Power Business Can Continue to Grow — And NI Stock Is Cheap AST SpaceMobile Stock Gets a New Catalyst. Wall Street Sees 93% Upside.
US Treasury Secretary Bessent: GENIUS Act establishes a federal regulatory framework for payment stablecoins
